Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-12-15

Clinical Trial Update: Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial evaluating temozolomide with radiation therapy for stage IV malignant melanoma with measurable and unresectable central nervous syst…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Temodar (Temozolomide)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Melanoma (Skin), Metastatic Cancer | Phase 2 | Status: TERMINATED